Compare Ginkgo Bioworks Holdings Inc (DNA) vs United States Natural Gas Fund (UNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs United States Natural Gas Fund — how do they compare? Ginkgo Bioworks Holdings Inc trades at $11.95 (market cap $763.64M), while United States Natural Gas Fund trades at $10.79 (market cap $517.27M). The key difference: Ginkgo Bioworks Holdings Inc is the larger of the two by market cap, and Ginkgo Bioworks Holdings Inc is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and United States Natural Gas Fund for 22 Days on average.
| DNA | UNG | |
|---|---|---|
Market Cap | $763.64M | $517.27M |
Volume | 3,204,177 | 29,485,537 |
Sector | Health | Commodities - Energy |
52-Week High | $15.83 | $16.90 |
52-Week Low | $5.48 | $9.63 |
Typical Hold Time | 7 Days | 22 Days |
Enterprise Value | $865.59M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $11.47, down 7.57% today, reflecting ongoing volatility. The stock shows a bullish technical signal with strong moving average support, but fundamentals reveal significant challenges: revenue declined to $170.16M in 2025 with a net loss of $312.76M, and negative cash flow persists. Recent news includes a partnership with TuneLab for AI-driven drug discovery and a $17.5M ARPA-H subcontract for RNA medicine manufacturing, indicating strategic growth initiatives amid financial headwinds.
The outlook remains high-risk due to persistent losses and cash burn, though analyst sentiment is split evenly between buy, hold, and sell. Upside potential hinges on successful commercialization of its platform and cost management, while downside risks include execution missteps and prolonged profitability challenges. Investors should weigh the company's innovative partnerships against its weak financial metrics.
UNG trades at $11.03, up 2.7% today, with a bullish technical signal from moving averages and neutral oscillators. The company reported a net income of $65.15 million in 2024 with no revenue, while cash flow from operations was positive at $47.54 million. Recent news highlights natural gas price volatility driven by record U.S. production and geopolitical tensions in the Middle East.
The outlook is mixed: strong profitability and low debt support fundamentals, but zero revenue and negative net cash flow pose risks. Geopolitical events and weather-dependent demand create volatility, making the stock sensitive to energy market shifts. Analyst sentiment is cautiously optimistic given the bullish technical setup.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →
